When is it right to reject an expensive new drug? University of Liverpool researchers Paul Atkinson and Sally Sheard respond to the UK’s recent…
A decade ago, families confronting an Alzheimer’s diagnosis had little more than memory-boosting pills aimed at lessening symptoms but they didn’t halt disease progression….
When people experience concerning memory problems — losing their keys more often, forgetting important events, or struggling to find the right word in the…
Researchers in China taught village health providers how to prescribe blood pressure medication. Despite not being doctors, this intervention lowered blood pressure and dementia…
Should “AD” stand for Alzheimer’s disease, or for Auguste Deter, the patient whose case was first described? Neurologist Donald Weaver explores the history. Auguste…
Two scientists at the University of Washington lay out how U.S. cuts to science research funding are expected to have a resounding public health…
The Alzheimer’s Association’s latest “Facts and Figures” report finds most Americans want early screening and access to disease-modifying drugs — even at high cost…
From clinical trials to funding cuts: Here’s how changes at NIH are reshaping Alzheimer’s and dementia research. As of September 2024, 495 clinical trials…
You’ve likely encountered Red Dye #3 before. It’s a common additive to many candies, beverages, baked goods, cereals, maraschino cherries and gelatin desserts, as…
A Trump executive order has banned DEI initiatives across the federal government. Scientists say the move could undermine trial diversity and derail the quest…
When Eisai announced in a press release this week that they’d secured FDA approval for an Alzheimer’s drug dosage change, it seemed like a…
Two days after President Donald Trump took office, sweeping bans — mostly temporary — went into effect across the U.S. National Institutes of Health…
This month, the U.S. Senate passed the Building Our Largest Dementia (BOLD) Infrastructure for Alzheimer’s Reauthorization Act of 2024. Originally signed into law in…
“No president has entered the White House with as clear a focus on Alzheimer’s disease as Joe Biden,” Maria Shriver and George Vradenburg wrote…
Climate change is making the symptoms of certain brain conditions worse, our new review has found. Conditions that can worsen as temperature and humidity…